Please find below all speakers involved in the national one day conference:

Chair of morning sessions

Alan Cameron




Prof Alan Cameron, Vice President Clinical Quality, Royal College of Obstetricians & Gynaecologists

Alan Cameron has been a consultant obstetrician in Glasgow for 22 years. He undertook his subspecialty training in Maternal Fetal Medicine at the University of Calgary, Alberta, Canada. Thereafter, he was appointed Lecturer in the Department of Obstetrics and Gynaecology in Glasgow University. Alan has retained an active research profile and was rewarded with an Honorary Professorship from the University of Glasgow in 2007. His main research interests are in prenatal diagnosis and fetal therapy. Alan has held the post of RCOG Vice President, Clinical Quality since September 2013, he is currently the RCOG representative on the National Screening Committee.

 Chair of morning sessions

Neena Modi

Prof Neena Modi, President, Royal College of Paediatrics and Child Health

Neena Modi is professor of Neonatal Medicine, Imperial College London, a consultant at Chelsea and Westminster Hospital and President of the Royal College of Paediatrics and Child Health. Neena qualified from the University of Edinburgh, and trained at University College Hospital London and Liverpool University. She leads a multidisciplinary neonatal research programme focussed on nutritional and other perinatal determinants of life-long health. Her team developed the National Neonatal Research Database, a resource of electronic data that is widely used by the health service. Neena is extensively published in peer-reviewed journals and directs the well-known ‘Neonatal Update: the science of newborn care’, a week-long annual international meeting. Neena has held a number of national roles including President of the UK Neonatal Society, President of the Academic Paediatrics Association, Chair of the British Medical Journal Ethics Committee, and Chair of the NHS England Infant, Children and Young People Patient Safety Expert Group.

Welcome and introduction


The Rt Hon Sir Nicholas Soames, Member of Parliament for Mid Sussex, House of Commons

Sir Nicholas Soames has been a Member of Parliament for 32 years and he has represented Mid Sussex since 1997. Sir Nicholas is a Group B Strep Support Patron and he has supported the campaign, both in and outside Parliament, to improve the prevention of group B Strep infection in newborn babies for many years.

Overview of neonatal Group B Streptococcal (GBS) disease – what it is and why it’s important

Alison Bedford-Russell

Dr Alison Bedford Russell, Consultant Neonatologist, Medical Director Birmingham Women’s NHSFT

Alison Bedford Russell is a medical director at Birmingham Women’s and Clinical Director for West Midlands Strategic Clinical Network for Women and Newborn. Alison’s research interests and publications have centred around neonatal infection, including research specifically related to Group B Streptococcus, and neonatal immunology. Alison also has expert advisor roles for BAPM (British Association of Perinatal Medicine); DH Infection in Critical Care Quality Improvement Programme (ICCQIP); national Group B Strep Support (GBSS) charity. She is also expert advisor to NICE Early Onset Neonatal Infection guideline development group; member of the Antibiotic resistance and health care associated infections (ARHAI) neonatal gram-negative infections sub-group, and she is responsible for publishing guidance for prevention and management of neonatal unit infections.

The burden of invasive Group B Streptococcal (GBS) disease in young infants in the UK & Republic of Ireland

Catherine O'Sullivan 2

Dr Catherine O’Sullivan, Research Fellow to Professor Paul Heath, Paediatric Infectious Diseases St George’s, University of London

Catherine O’Sullivan is a paediatric registrar and a clinical research fellow. She trained at Imperial College, London and has worked as a paediatric doctor in both England and Australia. She currently works in the Paediatric Infectious Diseases Research Group and Vaccine Institute at St. George’s, University of London. Catherine is involved in multiple research projects relating to perinatal and neonatal infection and in clinical vaccine trials. Her research to date has particularly focused on the current burden of invasive GBS disease and the long-term morbidity of neonatal meningitis and GBS sepsis.

Epidemiology of adult and infant GBS disease in England & Wales

Theresa Lamagni

Dr Theresa Lamagni, Senior Epidemiologist, Public Health England

Theresa Lamagni is a senior epidemiologist at Public Health England. She completed an MSc in Epidemiology at the London School of Hygiene & Tropical Medicine and a PhD on the epidemiology of severe group A streptococcal infections in Europe at the University of Helsinki. She came to work for the Public Health Laboratory Service Communicable Disease Surveillance Centre in 1995 as a research assistant within the HIV & STI department. In 2001, she joined the Healthcare Associated Infection & Antimicrobial Resistance Department where she currently manages a number of national surveillance programmes and has lead responsibility for streptococcal infection.

GBS prevention strategies – UK & International (risk based, screening and vaccination)

Philip Steer

Prof Philip Steer, Emeritus Professor of Obstetrics at Imperial College, Editor Emeritus of BJOG

Philip Steer was a consultant obstetrician for 26 years, latterly at the Chelsea and Westminster Hospital. Appointed Professor in 1989 (emeritus at Imperial College London from 2007). He is an editor of ‘High Risk Pregnancy – Management Options’ (fifth edition currently in preparation). He was President of the British Association of Perinatal Medicine from 1996 to 1999, President of the section of obstetrics and gynaecology of the Royal Society of Medicine 2008-9 and Editor-in-Chief of BJOG – an International Journal of Obstetrics and Gynaecology – from 2005-2012 (currently editor emeritus).

RCOG Recommendations/audit

Andrew Thomson

Dr Andrew Thomson, Co-Chair, Guidelines Committee, Royal College of Obstetricians & Gynaecologists

Andrew trained in Obstetrics and Gynaecology in the West of Scotland, obtaining his MRCOG in 1994, MD in 1999 and CCST in 2000. He has since worked as a consultant in Paisley (NHS Greater Glasgow & Clyde) where Andrew is a generalist with special interests in maternal and fetal medicine, and labour ward management. Andrew is enthusiastic about the development of clinical guidelines. He sat on the RCOG Guidelines Committee from 2010-2013, and became co-chair in 2014. Andrew was lead developer on two RCOG green-top guidelines (Thromboembolism and Antepartum Haemorrhage), and a development group member on the SIGN guideline on venous thromboembolism.

Chair of afternoon sessions

Prof Alan Cameron, Vice President Clinical Quality, Royal College of Obstetricians & Gynaecologists

Photo of Cathy Warwick

Prof Cathy Warwick, Chief Executive, Royal College of Midwives

Cathy Warwick CBE is Chief Executive of the Royal College of Midwives (RCM), one of the world’s oldest and largest midwifery organisations, representing the majority of the UK’s midwives. Cathy began her career by gaining a nursing degree at Edinburgh University in 1975. She then completed the one year midwifery course at Queen Charlotte’s Hospital in London in 1976, and worked as a midwife across a variety of clinical settings in hospitals and in the community. She has held a number of senior posts in midwifery education and in the NHS managing midwifery and nursing services. Prior to joining the RCM she was Director of Midwifery and General Manager for Women & Children’s Services at King College Hospital in London. She has an MSc in Social Policy, an Advanced Diploma in Midwifery (ADM) and a Post Graduate Certificate in Education of Adults. Her work has led to invitations to sit on many national maternity policy committees, and she has been Chair of the Midwifery Committee at the Nursing and Midwifery Council, and Chair of the maternity working group contributing to the Darzi report, Healthcare for London. Cathy has also written and published widely on midwifery issues and lectures and speaks nationally and internationally. She was awarded a visiting professorship by King’s College, London in 2004,

She received a CBE for Services to Healthcare in 2006, and was awarded an Honorary Doctorate from St George’s and Kingston University, London in 2007.

GBS Screening and laboratory diagnostics in the UK & Europe

Androulla Efstratiou

Prof Androulla Efstratiou, Director, WHO Global Collaborating Centre for Diphtheria & Streptococcal Infection

Androulla Efstratiou was awarded a PhD in medical microbiology by the University of London in 1987 and appointed as Senior Microbiologist in 1989 by the then Public Health Laboratory Service in London. In 1998, officially appointed as Head of the new WHO Global Collaborating Centre for Reference and Research on Diphtheria and Streptococcal Infections. Professor Efstratiou is currently a Consultant Public Health Microbiologist at Public Health England within which the WHO Centre is situated. She is Visiting Professor to the Faculty of Medicine, Department of Infectious Diseases, Imperial College, London. Other key appointments include; European Centre for Disease Control and Prevention (ECDC) UK Main Supervisor and Scientific Coordinator for the European Public Health Microbiology programme, EU Evaluator, WHO Consultant on diphtheria and streptococcal infections, Project Leader of the European Diphtheria Laboratory Surveillance Network.

Introducing a GBS screening programme in a UK setting

Gopal Guduru

Dr Gopal Rao OBE, Consultant Microbiologist, London North West Healthcare (LNWH) NHS Trust

Dr Gopal Rao is a consultant clinical microbiologist and lead clinician for infection prevention and control at London North West Healthcare (LNWH) NHS Trust. He has a longstanding interest in prevention of healthcare associated infections and has contributed to national and local policies for prevention and control of HCAI. Currently he is the Clinical Lead for the Group B Streptococcus (GBS) screening programme for prevention of neonatal GBS infections at the LNWH NHS Trust. He was awarded OBE in 2009 for services to medicine.

Midwife experience

Grace Nartey new

Mrs Grace Nartey, Matron Midwife, LNWH NHS Trust

Grace Nartey is the public health & named safeguarding lead midwife at the London North West Hospitals NHS Trust. She has been the public health lead at the Trust for 3 years and has always had a particular interest in public health. Grace leads the maternity public health service and focusses on the national and local public health agenda for Brent, Harrow and Ealing boroughs. She promotes and raises the awareness of the public health strategies in tackling issues affecting maternal and infant health. As part of the GBS team she is the lead midwife for the GBS antenatal screening programme.

Neonatal unit experience

Richard Nicholl new

Dr Richard Nicholl, Consultant Neonatologist, LNWH NHS Trust

Dr Richard Nicholl has worked as a neonatal paediatrician at Northwick Park Hospital, North West London since 1995. His interests in education and training include periods as RCPCH Tutor from 2001 to 2014 and clinical examiner for MRCPCH since 2010. He continues to be Foundation Year TPD working with local faculty to deliver the curriculum. He has been actively involved in teaching, practicing and publishing in evidence based medicine (e.g. Archimedes collection in Archives of Disease in Childhood) for many years. The neonatal unit has recruited to numerous multi-centre trials and trainees have published on a diverse range of neonatal topics, including infection.

Impact on congenital pneumonia and early onset sepsis in neonates

Reshmi Raychaudhuri

Dr Reshmi Raychaudhuri, LNWH NHS Trust

Reshmi Raychaudhuri graduated from Imperial College in London in 2009. She is currently completing her core paediatric training in the North West Thames rotation and is an ST5 paediatric trainee at Northwick Park hospital. She has recently completed her rotation in Neonates and would like to pursue a career in Neonatology.  

Maternal experience of newly introduced antenatal Group B strep screening in a UK hospital

FIona McQuaid

Dr Fiona McQuaid, Clinical Research Fellow, LNWH NHS Trust

Dr Fiona McQuaid is a Paediatric Registrar combining clinical training in London with academic work in Oxford and Edinburgh. She attended medical school at Imperial College London and recently spent a year as a paediatric research fellow at the University of Oxford. She has a particular interest in paediatric infectious disease, vaccination and research into the attitudes of women and healthcare professionals towards antenatal vaccines particularly for Group B strep. She is currently undertaking a PhD at the University of Edinburgh.

The legal viewpoint

Alison Eddy

Mrs Alison Eddy, Head of Clinical Negligence London, Irwin Mitchell 

Alison Eddy is the Managing Partner of the London office of Irwin Mitchell LLP. She heads the medical negligence team in London and specialises in claims for children who have suffered birth injury associated with permanent disability. She has practised in the field of medical negligence for over 30 years and is recognised as a “star leader“, a “first-rate” lawyer and “is commended for her wealth of experience handling brain and spinal injury work” (Chambers 2015). Alison has written many articles related to medical negligence, particularly relating to consent issues. She trains and advises on a variety of legal and health subjects, including for the Royal Colleges. Alison is a Fellow of the Association of Personal Injury Lawyers (APIL). She is legal secretary to the Clinical Disputes Forum and works with a number of charities, in particular Scope, Meningitis Now and Group B Strep Support.

Cost/benefit analyses

Tracy Roberts

Prof Tracy Roberts, Professor of Health Economics and Head of Unit, University of Birmingham

Tracy Roberts is Professor of Health Economics and Head of the Health Economics Unit at the University of Birmingham. Tracy has specific research interest in the area of economic evaluation and especially of testing and screening programmes, particularly in the areas of Sexual Health, Obstetrics and Gynaecology. Latterly she has developed interest in pursuing outcome valuation for use in economic evaluation in these clinical specialties. She has a wide range of applied research publications in these areas and has been a successful health economic applicant to both the MRC and NIHR on numerous grant applications.